Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report

BACKGROUND: Liver disease is the second cause of death among HIV patients receiving highly active antiretroviral therapy (HAART) in Europe. HIV patients have a high prevalence of chronic HBV (6–10%) and HCV (33%) co-infection, and accelerated progression of viral hepatitis. Furthermore, the long dur...

Descripción completa

Detalles Bibliográficos
Autores principales: De Nardo, Pasquale, Viscione, Magdalena, Corpolongo, Angela, Bellagamba, Rita, Vennarecci, Giovanni, Ettorre, Giuseppe Maria, Gentilotti, Elisa, Tommasi, Chiara, Nicastri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508865/
https://www.ncbi.nlm.nih.gov/pubmed/22741810
http://dx.doi.org/10.1186/1750-9378-7-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508865/
https://www.ncbi.nlm.nih.gov/pubmed/22741810
http://dx.doi.org/10.1186/1750-9378-7-15

Ejemplares similares